Early antibiotic stopping for fever with low white blood cells
Part of Blood & lymphatic, Cancer clinical trials.
This study tests whether it's safe to stop antibiotics early in patients who have had a fever while their immune system is weak from chemotherapy. If you've been fever-free for 48 hours, you may be able to avoid unnecessary antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- Your white blood cell count is expected to stay very low for a week or more.
- You are currently hospitalized at Mass General Brigham or Dana Farber Cancer Institute.
- You had a fever (temperature of 38.3°C or higher once, or 38.0°C or higher for at least an hour) while admitted.
- You have been without fever for at least 48 hours.
- You are not currently being treated for a bacterial infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adults with “high-risk febrile neutropenia” can safely get a shorter course of antibiotics. It may help reduce side effects from antibiotics while still keeping infections under control.
This trial studies whether proteins in your blood can predict complications when you have a fever and very low white blood cells after cancer treatment. It aims to help doctors choose the best antibiotics early on.
This trial tests whether an antibiotic called ceftazidime-avibactam (CAZ-AVI) can help patients with blood cancers who have a fever and very low infection-fighting white blood cells. It may be an option for people whose doctors plan to use this specific antibiotic to treat their fever.
This trial tests whether adding a medicine called G-CSF (which helps your body make more white blood cells) to standard antibiotics works better than antibiotics alone for children with fever and low white blood cells caused by cancer treatment.
This study tests whether adjusting antibiotic doses based on how fast your kidneys clear the medicine can better treat infections in children with cancer who have a fever and low white blood cells (neutropenia). It aims to improve recovery and reduce side effects.
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
Hear when a new Hematologic Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.